The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tandem Diabetes Care Inc shares valued at $190,966 were purchased by Kyrillos Jean-Claude on Mar 07 ’25. At $18.12 per share, Kyrillos Jean-Claude acquired 10,538 shares. The insider’s holdings grew to 10,538 shares worth approximately $0.17 million following the completion of this transaction.
Also, BLICKENSTAFF KIM D sold 30,000 shares, netting a total of over 941,400 in proceeds. Following the sale of shares at $31.38 each, the insider now holds 165,190 shares.
Before that, BLICKENSTAFF KIM D had sold 10,000 shares from its account. In a trade valued at $300,000, the Director traded Tandem Diabetes Care Inc shares for $30.00 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $3.16 million.
As published in a research note from Citigroup on July 09, 2025, Tandem Diabetes Care Inc [TNDM] has been rated down from a Neutral to a Sell and the price target has been revised to $14. Analysts at Truist started covering the stock with ‘”a Hold”‘ outlook in a report released in mid June. As of April 10, 2025, Mizuho has initiated its “Neutral” rating for TNDM. Earlier on March 05, 2025, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for TNDM stock which previously was a “an Overweight”.
Analyzing TNDM Stock Performance
On last trading session,, Tandem Diabetes Care Inc [NASDAQ: TNDM] rose 2.02% to $16.17. The stock’s lowest price that day was $15.46, but it reached a high of $16.26 in the same session. During the last five days, there has been a drop of approximately -5.33%. Over the course of the year, Tandem Diabetes Care Inc shares have dropped approximately -61.63%. Shares of the company reached a 52-week high of $38.28 on 01/06/25 and a 52-week low of $15.17 on 07/09/25.
Support And Resistance Levels for Tandem Diabetes Care Inc (TNDM)
According to the 24-hour chart, there is a support level at 15.67, which, if violated, would cause prices to drop to 15.16. In the upper region, resistance lies at 16.47. The next price resistance is at 16.76. RSI (Relative Strength Index) is 29.70 on the 14-day chart, showing oversold technical sentiment.
Is Tandem Diabetes Care Inc subject to short interest?
Stocks of Tandem Diabetes Care Inc saw a sharp rise in short interest on 2025-06-13 jumping by 1.12 million shares to 8.82 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 7.7 million shares. A jump of 12.7% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.31 of the overall float, the days-to-cover ratio (short ratio) jumped to 6.31.
Which companies own the most shares of Tandem Diabetes Care Inc (TNDM)?
#####
In terms of Tandem Diabetes Care Inc share price expectations, FactSet research, analysts set an average price target of 25 in the next 12 months, up nearly 57.73% from the previous closing price of $15.85. Analysts anticipate Tandem Diabetes Care Inc stock to reach 53 by 2025, with the lowest price target being 22. In spite of this, 10 analysts ranked Tandem Diabetes Care Inc stock as Buy at the end of 2025. On March 04, 2025, Citigroup assigned a price target of “a Neutral” to the stock and downgraded coverage with a $24.
